[ Price : $8.95]
A letter from dozens of biotechnology industry executives and investors urges FDA commissioner Marty Makary to reject efforts to r...[ Price : $8.95]
FDA drops REMS requirements covering embryofetal toxicity risk in endothelin receptor antagonists.[ Price : $8.95]
FDA warns Lenoir, NC-based Exela Pharma Sciences about CGMP violations in its work as a drug manufacturing outsourcing facility.[ Price : $8.95]
Forty health advocacy groups led by the Association for Accessible Medicines voice their support for legislation to eliminate the ...[ Price : $8.95]
A Federation of American Scientists online paper says FDA, other federal research agencies, and Congress should take steps to incr...[ Price : $8.95]
Taiho Pharmaceutical reports disappointing data from its Phase 3 extension study of TAS-205 (pizuglanstat) in patients with Duchen...[ Price : $8.95]
A bioethicists opinion piece in The Hill says FDA needs to expand its reliance on real-world clinical data to monitor the safety a...[ Price : $8.95]
FDA accepts and will give priority review to a Merck sBLA for a Winrevair labeling update based on ZENITH trial results.